Search clinical trials for: efgartigimod PH20 SC

Total 574 results

Manchester University NHS Foundation Trust
Northern Care Alliance NHS Foundation Trust

Recruiting

Enhanced Rehabilitation After Major Trauma (PROPERLY) (PROPERLY)

Major Trauma

United Kingdom
Halozyme Therapeutics

Completed

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type II

United States
Takeda

Completed

Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis

Colitis, Ulcerative

United States, Korea, Republic of, Netherlands, Australia, Denmark, Russian Federation, Spain, Croatia, Israel, Serbia, Bulgaria, Canada, Italy, Poland, Ukraine, Hungary, Belgium, Czechia, Turkey, Germany, Japan, Estonia, Mexico, Romania and more
Eli Lilly and Company

Completed

A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women

Healthy

United States
Seattle Children's Hospital

Recruiting

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma | Refractory Primary Malignant Central Nervous System Neoplasm | Recurrent CNS Tumor, Adult | Recurrent, CNS Tumor, Childhood

United States
Eli Lilly and Company

Recruiting

A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

Alzheimer's Disease

United States, Japan
Eli Lilly and Company

Completed

A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis

Psoriasis

United States
Eli Lilly and Company

Completed

A Study of LY2541546 in Healthy Postmenopausal Women

Healthy

United States
Universitair Ziekenhuis Brussel

Completed

Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.

Survival | Embryo Quality

Belgium
Centre for Human Drug Research, Netherlands
Leiden University Medical Center; Leiden Academic Center for Drug Research,...

Completed

Adalimumab Microneedles in Healthy Volunteers

Pain | Injection Site

Netherlands
AbbVie

Completed

A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

United States, Japan, Korea, Republic of, Taiwan
Janssen Research & Development, LLC

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy Participants

Healthy

Belgium
Jordan F. Karp

Withdrawn

Deep Brain Stimulation to Relieve Depression (DRIVER)

Treatment Resistant Depression
University of Cologne
German Federal Ministry of Education and Research; Heinrich-Heine University... and other collaborators

Unknown

Psychological Intervention for Persons in the Early Initial Prodromal State

Schizophrenia | Psychosis

Germany
Merck Sharp & Dohme LLC

Completed

Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)

Hepatitis B
Anergis

Terminated

Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen (AN003)

Allergy | Allergic Rhinitis

Switzerland
Hoffmann-La Roche

Recruiting

A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 in Participants With Multiple Sclerosis.

Multiple Sclerosis

Belgium, Portugal, United States, Italy, Poland, Germany, Canada, Israel, Moldova, Republic of, Romania
Janssen Pharmaceutical K.K.

Completed

A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Japan
Columbia University

Completed

Family Nurture Intervention in the NICU at The Valley Hospital

Premature Birth | Obstetric Labor, Premature

United States
University of Helsinki
Helsinki University Central Hospital; University of Virginia; University of Jyvaskyla and other collaborators

Completed

Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury (MUBI)

Traumatic Brain Injury (TBI)

Finland
MedImmune LLC

Completed

A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease (SPRING)

Chronic Obstructive Pulmonary Disease

United States, Bulgaria, Czech Republic, Poland, United Kingdom, Philippines, Latvia, Lithuania, Ukraine, Hungary
StemCells, Inc.

Completed

Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)

Pelizaeus-Merzbacher Disease | PMD

United States
Marius Henriksen

Terminated

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (TOCIVID)

Corona Virus Disease

Denmark
Columbia University
Einhorn Family Charitable Trust

Completed

Family Nurture Intervention in the NICU

Premature Birth | Obstetric Labor, Premature

United States
Eli Lilly and Company

Terminated

A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Healthy | Mild Cognitive Impairment | Alzheimer's Disease

United States, Japan
The University of Hong Kong

Completed

Promoting Smoking Cessation for Female Smokers in Hong Kong Through Training Female Youth SCRA

Smoking Cessation

China
Elastagen Pty Ltd

Completed

Safety Study of Three Formulations of the Dermal Implant ELAPR

Skin Conditions

Australia
AbbVie

Recruiting

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Israel
StemCells, Inc.

Terminated

Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Age-Related Macular Degeneration | Geographic Atrophy

United States
Pfizer

Completed

A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy (ANDANTE)

Crohn's Disease

United States, Denmark, Ireland, Australia, Belgium, Israel, Italy, Canada, Czech Republic, Hungary, Germany, United Kingdom, Brazil, New Zealand, France, Greece, Switzerland, Romania
Celltrion

Completed

A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria
Ege University

Completed

6-year Clinical Evaluation of Glass Ionomer Cements (GIS) With Resin Coating on Posterior Teeth (GIS)

Dental Caries
Sanofi Pasteur, a Sanofi Company
Sanofi K.K.

Completed

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years

Influenza

Japan
Pfizer
Eli Lilly and Company

Completed

A Phase 3 Study of Tanezumab for Chronic Low Back Pain (TANGO)

Low Back Pain

United States, Spain, Korea, Republic of, Japan, Canada, Hungary, France, Sweden, Denmark
University of Adelaide

Completed

Daily vs Intermittent Restriction of Energy: Controlled Trial to Reduce Diabetes Risk (DIRECT)

Individuals at Risk of Developing Diabetes

Australia
University of South Florida

Unknown

Distress Tolerance Treatment for Substance Users

Substance Dependence

United States
Pfizer

Completed

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859

Healthy

United States
StemCells, Inc.

Completed

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

Macular Degeneration | Age Related Macular Degeneration | AMD

United States
MedImmune LLC

Completed

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis, Relapsing Forms

United States, Spain, Poland, Ukraine
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Ulcerative Colitis

Poland
Janssen-Cilag International NV

Completed

A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy Volunteers

Healthy

Belgium
Vanderbilt University Medical Center
Sanofi

Completed

Characteristics of Glargine in Type 2 Diabetics

Type 2 Diabetes

United States
Columbia University
National Institute on Minority Health and Health Disparities (NIMHD); Icahn... and other collaborators

Active, not recruiting

Music Intervention for Preterm Birth

Preterm Birth

United States
University of Iowa
University of Washington; University of Minnesota

Completed

Pre-Implementation Enhancement Strategy To Improve Teachers' Intention to Implement Evidence-Based Practices (SC-PIES)

Implementation Science | Child Behavior Disorders | Healthcare Providers | Adolescent Problem Behavior at School
University of Pittsburgh
West Penn Allegheny Health System

Completed

Reducing Depressive Symptoms in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UNIFI)

Inflammatory Bowel Diseases | Colitis, Ulcerative

United States, Australia, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Israel, Bulgaria, Romania, Serbia, Japan, Canada, Netherlands, Korea, Republic of, New Zealand, Russian Federation, Austria, Hungary, Slovakia, D... and more
Biogen

Completed

Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS) (REFINE)

Relapsing-Remitting Multiple Sclerosis

France, Italy, Spain, Germany, Belgium
Human Genome Sciences Inc.
GlaxoSmithKline

Completed

Study of Belimumab Administered Subcutaneously to Healthy Subjects

Healthy

United States
Eli Lilly and Company

Completed

Safety Study of LY3041658 in Healthy Participants

Healthy

United States
Eli Lilly and Company

Completed

Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis

Inflammatory Arthritis

Bulgaria, Georgia, Moldova, Republic of, Romania

Search clinical trials for: efgartigimod PH20 SC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations